Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-Current Debt
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Cash from Investing Activities: 2018-2024

Historic Cash from Investing Activities for CureVac N.V (CVAC) over the last 7 years, with Dec 2024 value amounting to -$19.7 million.

  • CureVac N.V's Cash from Investing Activities rose 78.17% to -$1.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$8.7 million, marking a year-over-year increase of 80.17%. This contributed to the annual value of -$19.7 million for FY2024, which is 66.82% up from last year.
  • Per CureVac N.V's latest filing, its Cash from Investing Activities stood at -$19.7 million for FY2024, which was up 66.82% from -$59.4 million recorded in FY2023.
  • CureVac N.V's 5-year Cash from Investing Activities high stood at -$19.7 million for FY2024, and its period low was -$146.3 million during FY2021.
  • Over the past 3 years, CureVac N.V's median Cash from Investing Activities value was -$59.4 million (recorded in 2023), while the average stood at -$58.2 million.
  • As far as peak fluctuations go, CureVac N.V's Cash from Investing Activities crashed by 273.05% in 2020, and later spiked by 66.82% in 2024.
  • Yearly analysis of 5 years shows CureVac N.V's Cash from Investing Activities stood at -$54.0 million in 2020, then tumbled by 171.06% to -$146.3 million in 2021, then soared by 34.80% to -$95.4 million in 2022, then surged by 37.74% to -$59.4 million in 2023, then surged by 66.82% to -$19.7 million in 2024.